BEVERLY HILLS, Calif.–(CRWENewswire)– DAVI LUXURY BRAND GROUP, INC. (OTC Bulletin Board: MDAV) today announced that it has collaborated with KOREAN AIR and Harmony to create a unique DAVI Luxury amenity skin care line and travel bag exclusively for Korean Airlines and its First and Business (Prestige) class passengers. Korean Air will provide the DAVI amenity travel bags to its passengers commencing in May 2011.

The selection by Korean Air of DAVI LUXURY BRAND GROUP’s “DAVI” and “DAVI Skin” brands joins two brands with exceptional legacies and an appreciation for quality and tradition. Korean Air is one of the world’s premier airlines with a fleet of 129 planes that provide service to 39 countries, 113 cities and 20 million plus customers annually. Korean Air is recognized as being one of the best luxury airlines in the world and consistently wins awards in all categories.

“We are delighted to provide our passengers with DAVI’s high quality skincare products. Providing these DAVI amenity skincare kits to our passengers is consistent with our goal to remain one of the world’s premier airlines and to continuously innovate and upgrade our customer services,” said Heather Cho, senior vice president at Korean Air. “We expect that Korean Air and DAVI will jointly benefit from this alliance, and that this service will contribute to the success of our airline as we plan to soon showcase the new A380 addition to our fleet,” said Heather Cho.

The Korean Air amenity bags, and the skincare line included in the bags, were designed and made exclusively for Korean Airlines in collaboration with Harmony and Korean Air. The Korean Air product line currently includes DAVI’s Le Grand Cru face creme and Coastal Vine after shave. In addition, products developed exclusively for and with Korean Air include hand and body lotion, cooling eye gel, lip balm and pulse point calming oil.

“We are greatly honored to be the luxury in-flight amenity provider for Korean Air. Korean Airlines consistently delivers the best in-flight experience in the business to its passengers, and we are pleased to be able to contribute to enhancing the in-flight experience of Korean Air’s passengers. DAVI looks forward to making this partnership one of the finest in the industry,” said Carlo Mondavi, Chairman of the Board of Directors of DAVI LUXURY BRAND GROUP.

The DAVI luxury skin care kits come in stylish beige and maroon bags, carefully crafted and bearing the DAVI brand’s name and logo with the add-on “Exclusive for KOREAN AIR.” In addition to the travel amenity kits for first class and business class passengers, Korean Air also intends to provide DAVI hand and body lotion in its restrooms and airport lounge facilities.

“Harmony is the leading premium airlines amenity kit provider, and we are extremely proud and privileged to partner with DAVI LUXURY BRAND GROUP. Because of the high quality of the DAVI products, we early on realized that the DAVI products were a perfect match for Korean Air. It has been a pleasure working with Carlo Mondavi and Parrish Medley in developing this product line for KOREAN AIR. We can see tremendous opportunities with the DAVI brand,” said Shaun Wylie Managing Director of Harmony.

“Providing DAVI skincare products to the first class passengers of KOREAN AIR is a tremendous opportunity to expose our ‘DAVI’ brand and our products to millions of affluent customers. I believe that this is an important step in our plan to distribute our luxury quality skincare products to top class customers worldwide, and a strong validation of our business plan,” said Parrish Medley, Chief Executive Officer of DAVI LUXURY BRAND GROUP.

About DAVI LUXURY BRAND GROUP INC. (OTC Bulletin Board:MDAV)

DAVI LUXURY BRAND GROUP, INC., founded by Carlo Mondavi, grandson of American Icon Robert Mondavi, develops, licenses and markets luxury skin care products using the antioxidants found in wine and grapes. The company markets skincare products under the “DAVI Skin” and “DAVI” brand names. The products currently are provided as amenities at prestige hotels and as first class in-flight airline amenities. The company’s goal is to also market its branded skincare products through upscale department stores, specialty retailers, prestige resorts, salons and spas, on cruise ships, and through airline duty-free shops. The company’s skincare products contain minerals, vitamins and nutrients that are found in a by-product of the wine making process called the pomace. Planting techniques at select vineyards produce deeper vines with a lower yield of grapes per vine. After processing, these grapes yield higher concentrations of minerals, vitamins, and nutrients than grapes from other vineyards. Additionally, the uniquely long maceration process to which these grapes are subjected, yield polyphenols in relatively high quantity. Polyphenols are the free radical scavengers that, among other things, help to protect collagen and elastin fibers and prevent the destruction of hyaluronic acid in the skin. Management believes that the use of this pomace will allow for the creation of skin crèmes that can help fight the natural aging process of the skin.

WWW.DAVISKIN.COM (OTC Bulletin Board: MDAV)
WWW.DAVILUXURYBRANDGROUP.COM (OTC Bulletin Board: MDAV)

About KOREAN AIR

KOREAN AIRLINES was established in 1969 and is one of the world’s premier airlines with a fleet of 129 planes, that provides service to 39 countries, 113 cities and servicing 20 million plus customers annually. Korean Air has a long-standing commitment to achieving “Excellence in Flight.” Korean Air has announced its launch of the A380 service to Japan and Hong Kong starting from June 2011. Korean Air will gradually expand its A380 service to Bangkok, New York and Los Angeles later this year. The introduction of the A380 is expected to increase passengers from China, Japan, and East Asia in transit to the US and Europe. WWW.KOREANAIR.COM

About Harmony

Harmony is a division of gategroup.

gategroup is the leading independent global provider of products and services related to a passenger’s onboard experience. We specialize in catering and hospitality; provisioning and logistics; and onboard solutions to companies that serve people on the move. Our customers include top airlines and railroads around the world that rely on our expertise and solutions tailored to their guests, service offerings and geographic regions.

Our portfolio includes the following established brands: deSter, eGate Solutions, Elan, Gate Aviation, Gate Gourmet, Gate Safe, Harmony, Performa, potmstudios, Pourshins and Supplair. We are passionate about helping our customers satisfy thousands of their guests around the world every day. The combination of our commitment and expertise has made gategroup one of the industry’s leaders, a reputation we strive to fulfill daily. Harmony is the leading global provider of premium airline amenity kits and comfort items, as well as being a total integration airline service provider. Harmony offers and develops an impressive and distinctive range of unequalled comfort solutions. Working together with exclusive international brands, Harmony provides cabin concepts in which trendsetting designs and down-to-earth practically go hand-in-hand. Harmony has offices in Europe, Asia and the U.S., ensuring dedicated and customized service. We count many of the world’s most prestigious airlines among our customers.

WWW.HARMONYONBOARD.COM
WWW.GATEGROUPMEMBER.COM

Safe Harbor Statement

THIS PRESS RELEASE INCLUDES STATEMENTS THAT MAY CONSTITUTE “FORWARD LOOKING” STATEMENTS. FORWARD LOOKING STATEMENTS INHERENTLY INVOLVE RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM CURRENT EXPECTATIONS. BY MAKING THESE FORWARD LOOKING STATEMENTS, THE COMPANY UNDERTAKES NO OBLIGATION TO UPDATE THESE STATEMENTS FOR REVISIONS OR CHANGES.

Contact:

DAVI LUXURY BRAND GROUP, INC.
Mr. Parrish Medley, Beverly Hills, 310-288-8393
parrishmedley@daviskin.com
WWW.DAVILUXURYBRANDGROUP.COM
WWW.DAVISKIN.COM

Source: DAVI LUXURY BRAND GROUP, INC.

*********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at http://www.crwenewswire.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

In 1966, Robert Mondavi founded a winery with a mission to create a California wine that would stand up to the elite wines of the world. The result is a brand synonymous with quality and California wines the world over.

Forty years later, his grandson Carlo Cesare Mondavi has ventured out from his family’s sacred Napa Valley vineyards to create something alike in the skincare business—a luxury product that not only reflects the California lifestyle fostered by his family’s wine, but performs better than the already established skincare regimes available today.

He turned to what he knew best, as a third generation vintner, Carlo Mondavi has created a line of skincare with roots firmly planted in his family’s vineyards. The result is Davi, a new line of luxury skincare encompassing the unique byproducts of the winemaking process coupled with the latest innovations in modern technology.

Davi Luxury Brand Group, Inc. (OTCBB:MDAV) develops, licenses and markets luxury skin care products using the antioxidants found in wine and grapes.

MDAV markets skincare products under the “DAVI Skin” and “DAVI” brand names. The products currently are provided as amenities at prestige hotels and as first class in-flight airline amenities.

MDAV’s goal is to also market its branded skincare products through upscale department stores, specialty retailers, prestige resorts, salons and spas, on cruise ships, and through airline duty-free shops.

MDAV’s skincare products contain minerals, vitamins and nutrients that are found in a by-product of the wine making process called the pomace. Planting techniques at select vineyards produce deeper vines with a lower yield of grapes per vine. After processing, these grapes yield higher concentrations of minerals, vitamins, and nutrients than grapes from other vineyards. Additionally, the uniquely long maceration process to which these grapes are subjected, yield polyphenols in relatively high quantity.

Polyphenols are the free radical scavengers that, among other things, help to protect collagen and elastin fibers and prevent the destruction of hyaluronic acid in the skin.

It is believed that the Americans are obsessed with anti aging concepts because the number of men and women put together who buy anti aging products is more than 9 million.

Anti aging alone in the medical field has become a multi billion dollar industry. Almost every one of us is scared of growing old and will try our best to stay and look younger for as long as we can. Even a slight remark about a gray hair or wrinkle can upset people.

Many of them go to great lengths in trying to remove the wrinkles and opt for skin treatments. Aging symptoms are clearly visible and that is why they worry people the most.

A popular research shows that nearly 90 million people in America have used anti aging products at some time or the other in their life. Most of them have also found to be using the products which are available off the shelf and popularized through advertisements.

Very few of them have actually consulted dermatologists or taken professional treatment for aging signs. Also, few of them have gone though extreme cosmetic surgeries.

Overall the number of people found to be using these creams became a stunning figure in numbers. On the other hand, the demand for natural and herbal treatments is also on the rise with more and more people trying them out. There is a lot of desperation in people to continue looking younger and people find it very hard to come in terms with their aging skin in spite of being old.

According to BCC Research, the global anti aging industry is expected to reach $274 billion by the year 2013.

MDAV’s management believes that the use of this pomace will allow for the creation of skin crèmes that can help fight the natural aging process of the skin.

More about Davi Luxury Brand Group, Inc. (OTCBB:MDAV) at www.daviskin.com

*******************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at http://www.crwenewswire.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Proteonomix (PROT.OB) notes the favorable similarity between technology involved in the Cephalon, Inc. (CEPH) transaction with Australian company Mesoblast Limited.

Michael Cohen, the Company’s founder and CEO stated, “We applaud the transaction between Cephalon and Mesoblast and take this opportunity to note that our StromaCel® bone marrow derived stem cell technology attacks similar medical problems with a different approach.”

Mr. Cohen continued, “Our StromaCel® technology is also designed to treat damage to cardiac tissue caused by myocardial infarction (MI) and we are actively seeking funding to open clinics worldwide to treat MI patients. This technology was developed in conjunction with the University of Miami where bone marrow derived stem cells are undergoing Phase I trials. We are seeking joint venture partners to give effect to this strategy.”

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix. StromaCel, Inc.’s goal is the development of therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (”PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

***************************

Crown Equity Holdings Inc. (OTCBB:CRWE) announced recently that it is expanding its business by opening another office in Pakistan. This office will be located in the city of Attock, Pakistan. This office will add an additional workforce of 25 associates to its CRWENewswire team, which will increase the company’s up to date news and world affairs from the Mid-East, Far East and Europe online news wires.

The new office in the city of Attock, as well as the office in Islamabad, will be managed by Zeeshan Shabbir.

Crown Equity Holdings is in the process of developing its Arabic language CRWENewswire site for news occurring in Pakistan and elsewhere around the world.

***************************

Fuwei Films (Holdings) Co., Ltd. (Nasdaq:FFHL) recently announced that management has become aware of a sharp increase in the Company’s stock price over the past three months, since the announcement of the settlement of the class action litigation against the Company on September 20.

Fuwei Films (Holdings) Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and distribution of plastic film using the biaxial oriented stretch technique, known as BOPET film (biaxially oriented polyethylene terephthalate).

***************************

Myrexis, Inc. (Nasdaq:MYRX) recently announced it has initiated a controlled two-arm Phase 2b clinical study of Azixa (verubulin) as a front-line treatment for glioblastoma multiforme (GBM). In previous Phase 2 studies, Azixa demonstrated potent, durable antitumor responses without any additive toxicity.

Myriad Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel small molecule drugs for the treatment of diseases with high unmet need, including cancer and HIV infection.

***************************

MoSys, Inc. (NasdaqGM:MOSY) recently announced that Len Perham, President and Chief Executive Officer, and Jim Sullivan, Chief Fincial Officer, will present at the 13th Annual Needham Growth Stock Conference to be held at the New York Palace Hotel in New York, NY. Management is scheduled to present at 10:00 a.m. (Eastern Time) on Wednesday, January 12, 2011, and will available to meet with investors throughout the day. Portfolio managers and analysts who wish to meet with management at the conference should contact their Needham & Company, LLC representative or email conferences@needhamco.com.

MoSys, Inc. designs, develops, markets, and licenses embedded memory intellectual property (IP) used by the semiconductor industry and communications, networking, and storage equipment manufacturers.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has previously received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services (which has expired) for Proteonomix, Inc. (PROT.OB)

Proteonomix (PROT.OB) a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to provide an update on the Company’s addition to its Board of Directors. Proteonomix, Inc. is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors.

In February, 2010, he was appointed to the Board of Directors of The Foundation for the Accreditation of Cellular Therapy (FACT). Founded in 1996, FACT establishes standards for high quality medical and laboratory practice in cellular therapies. It is a non-profit corporation co-founded by the International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation (ASBMT) for the purposes of voluntary inspection and accreditation in cellular therapy field. The major objective of FACT is to promote high quality patient care and laboratory performance in the belief that a valid accreditation must assess both clinical and laboratory aspects.

In 2000, recognizing the global impact of cord blood banking and transplantation, FACT co-developed international standards for cord blood collection, processing, testing, banking, selection and release. In 2006, FACT collaborated to establish international standards in the field of cellular therapy by international teams of experts in cellular therapy and cord blood banking fields. The standards contain the minimum guidelines for facilities and individuals performing cellular therapy product transplantation, cord blood banking, or providing support services for such activities. On-site inspections are carried out by a team of inspectors who are qualified by training and experience, have attended inspector training and who have a working knowledge of FACT. The inspection process is quality-oriented and follows the FDA’s rules for current Good Tissue Practice.

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (”PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

**************************************

Global Hunter Corp. (TSX.V: BOB) (FSE:G5D) is pleased to announce that it recently completed a surface sampling program at La Corona de Cobre. The program was designed to collect surface samples from the numerous prospective shear zones. This will aid in the definition of drill targets to expand on the copper oxide mineralization.

The samples will be collected from outcrops along the entire strike lengths of the shears and have been shipped to ALS Chemex Labs in La Serena Chile for analysis. Results will be released as soon as is practical after they have been received.

These shear zones can be traced on surface for hundreds of metres, with the longest being Vino Fino, which has been mapped for over 6,000 metres. Local miners are currently extracting ore from several shear zones on the property and transporting it to Enami for processing.

The surface sample results in conjunction with previous geophysical work completed on the property, Global Hunter intends to prepare a multi-hole drill program on the shear zones scheduled to begin early 2011 as part of its ongoing evaluation of its Corona de Cobre project. In addition to sampling and drilling of the prospective shear zones at La Corona de Cobre mentioned above, The Company will continue its work on the Las Posadas resource over the coming months and will provide a summary of its progress as information becomes available.

Global Hunter’s flagship project is the La Corona de Cobre property, located 70 kilometres north of La Serena, Chile, along the Pan American Highway, within the coastal belt of the Andean Cordillera. The NI 43-101-compliant resource contains 225 million pounds of copper oxide. In addition, the Company has its Rabbit South molybdenum project in south-central British Columbia, Canada.

For More Information Go To: www.globalhunter.ca

**************************************

The Allstate Corporation (NYSE:ALL) announced the launch of Drive Wise, a voluntary program that rewards safe and low-mileage Illinois drivers with discounts of up to 30 percent. The company plans to expand Drive Wise to other states as early as Q2 2011. Consumers can learn more and sign up for the program by contacting their local Allstate agent.

The Allstate Corporation, through its subsidiaries, engages in the personal property and casualty insurance business, as well as in the life insurance, retirement, and investment products business in the United States and Canada.

**************************************

NYSE Euronext, Inc. (NYSE:NYX) will host an investor day for the professional investment community on Tuesday, March 8, 2011, at the New York Stock Exchange, 11 Wall Street, New York, NY. The day’s schedule will commence with opening remarks at 8:30a.m.will expected to conclude at approximately 12:30p.m. Presenters at the conference will include Duncan L. Niederauer, Chief Executive Officer, NYSE Euronext, and other members of the company’s executive management team.

NYSE Euronext, through its subsidiaries, provides securities listing, trading, market data products, and software and technology services worldwide. The company offers products and services in cash equities, futures, options, swaps, exchange-traded products, bonds, market data, and commercial technology solutions to issuers, investors, financial institutions, and market participants.

**************************************

Owens Corning (NYSE:OC) announced that it has reached a definitive agreement with Boral Industries Ltd. to sell its Masonry Products business. The divestiture will be in two stages. Owens Corning will sell a 50 percent stake in its Masonry Products business to Boral Industries Ltd. for $45 million at closing. The Masonry Products business will then be operated jointly until early 2014. At that time, Owens Corning will sell its remaining 50 percent stake for $45 million and may receive additional proceeds dependent upon 2013 financial performance.

Owens Corning, through its subsidiaries, provides composite and building materials systems worldwide. It operates in two segments, Composites and Building Materials.

************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) has previously received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services (which has expired) for Proteonomix, Inc. (PROT.OB)

Crown Equity Holdings Inc. (CRWE.OB) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.V:BOB) and the Frankfurt Stock Exchange (FSE:G5D)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company.